blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0862577

EP0862577 - SULPHAMATE DERIVATIVES OF 1,3,5(10)-ESTRATRIENE DERIVATIVES, METHODS OF PRODUCING THEM AND PHARMACEUTICAL COMPOUNDS CONTAINING THEM [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.02.2000
Database last updated on 31.08.2024
Most recent event   Tooltip18.02.2000No opposition filed within time limitpublished on 05.04.2000 [2000/14]
Applicant(s)For all designated states
Jenapharm GmbH & Co. KG
Otto-Schott-Strasse 15
07745 Jena / DE
[1999/13]
Former [1998/37]For all designated states
JENAPHARM GmbH
Otto-Schott-Strasse 15
D-07745 Jena / DE
Inventor(s)01 / SCHWARZ, Sigfrid
Ottogerd-Mühlmann-Strasse 17
D-07743 Jena / DE
02 / ELGER, Walter
Schorlemerallee 12b
D-14195 Berlin / DE
03 / REDDERSEN, Gudrun
Hügelstrasse 25
D-07749 Jena / DE
04 / SCHNEIDER, Birgitt
Damaschkeweg 19
D-07745 Jena / DE
05 / THIEME, Ina
B. Siedlung 12
D-07616 Graitschen / DE
06 / RICHTER, Margit
Boegeholdstrasse 19
D-07745 Jena / DE
[1998/37]
Representative(s)Wablat, Wolfgang
Patentanwalt
Dr. Dr. W. Wablat
Potsdamer Chaussee 48
14129 Berlin / DE
[N/P]
Former [1998/37]Wablat, Wolfgang, Dr.Dr.
Patentanwalt, Potsdamer Chaussee 48
14129 Berlin / DE
Application number, filing date96945140.019.09.1996
[1998/37]
WO1996DE01823
Priority number, dateDE199514023319.10.1995         Original published format: DE 19540233
[1998/37]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report
No.:WO9714712
Date:24.04.1997
Language:DE
[1997/18]
Type: A2 Application without search report 
No.:EP0862577
Date:09.09.1998
Language:DE
The application published by WIPO in one of the EPO official languages on 24.04.1997 takes the place of the publication of the European patent application.
[1998/37]
Type: B1 Patent specification 
No.:EP0862577
Date:14.04.1999
Language:DE
[1999/15]
Search report(s)International search report - published on:EP05.06.1997
ClassificationIPC:C07J41/00, A61K31/565
[1998/37]
CPC:
C07J41/0072 (EP); A61P5/32 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1998/37]
TitleGerman:SULFAMAT-DERIVATE VON 1,3,5(10)-ESTRATRIEN-DERIVATEN, VERFAHREN ZU IHRER HERSTELLUNG UND DIESE VERBINDUNGEN ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN[1998/37]
English:SULPHAMATE DERIVATIVES OF 1,3,5(10)-ESTRATRIENE DERIVATIVES, METHODS OF PRODUCING THEM AND PHARMACEUTICAL COMPOUNDS CONTAINING THEM[1998/37]
French:DERIVES SULFAMATE DE DERIVES 1,3,5(10)-ESTRATRIENE, PROCEDE DE PRODUCTION CORRESPONDANT ET COMPOSITIONS PHARMACEUTIQUES RENFERMANT CES COMPOSES[1998/37]
Entry into regional phase30.03.1998National basic fee paid 
30.03.1998Designation fee(s) paid 
30.03.1998Examination fee paid 
Examination procedure10.04.1997Request for preliminary examination filed
International Preliminary Examining Authority: EP
30.03.1998Examination requested  [1998/37]
05.10.1998Despatch of communication of intention to grant (Approval: Yes)
18.12.1998Fee for grant paid
18.12.1998Fee for publishing/printing paid
15.02.1999Communication of intention to grant the patent
Opposition(s)15.01.2000No opposition filed within time limit [2000/14]
Fees paidRenewal fee
20.07.1998Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]DE1949095  (JENAPHARM VEB) [A] 1-3 * page 3, line 9 - line 18; examples 27-29 *;
 [A]FR2133484  (JENAPHARM VEB [DD]) [A] 1-3 * examples 21-23,25,27 *;
 [A]  - W. STÖLZNER ET AL, "Untersuchungen zur Dissoziation zwischen antigonadatrophen und interzeptiven Aktivitäten ausgewählter Östratrienderivate", PHARMAZIE, BERLIN DE, (197501), vol. 30, no. 1, pages 52 - 53, XP002026377 [A] 1-3 * the whole document *
 [A]  - S. SCHWARZ ET AL, "Steroide 15. Mitteilung: Sulfonyloxyderivate von Östrogenen", PHARMAZIE, BERLIN DE, (197501), vol. 30, no. 1, pages 17 - 21, XP002026378 [A] 1-3 * the whole document *
 [PA]  - W. ELGER ET AL, "Sulfamates of Various Estrogens are Prodrugs with Increased Systemic and Reduced Hepatic Estrogenicity at Oral Application", JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, (19951229), vol. 55, no. 3/4, pages 395 - 403, XP002026379 [PA] 1-3 * the whole document *

DOI:   http://dx.doi.org/10.1016/0960-0760(95)00214-6
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.